Tamoxifen and the risk of Parkinsonism: a case/non-case study.
Montastruc F, Khosrow-Khavar F, de Germay S, Renoux C, Rousseau V, Durrieu G, Montastruc M, Rascol O, Sommet A, Lapeyre-Mestre M, Benevent J, Montastruc JL.
Montastruc F, et al. Among authors: sommet a.
Eur J Clin Pharmacol. 2018 Sep;74(9):1181-1184. doi: 10.1007/s00228-018-2496-3. Epub 2018 Jun 3.
Eur J Clin Pharmacol. 2018.
PMID: 29862427